The global Peptide Drug Conjugates Market is experiencing significant growth, driven by increasing interest in targeted drug delivery technologies and advancements in pharmaceutical research. The market size is expected to reach US$ 25.41 billion by 2034, rising from US$ 4.54 billion in 2025. The market is anticipated to register a CAGR of 21.09% during the forecast period 2026–2034....
